Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index
van Spronsen, M.F, Ossenkoppele, G.J, Holman, R, van de Loosdrecht, A.A
Published in European journal of cancer (1990) (01.12.2014)
Published in European journal of cancer (1990) (01.12.2014)
Get full text
Journal Article
Response to letter commenting on: Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System
van Spronsen, M.F, Witte, B.I, Ossenkoppele, G.J, Westers, T.M, van de Loosdrecht, A.A
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
282 COMBINATION OF LENALIDOMIDE AND AZACITIDINE INDUCES PRO-INFLAMMATORY SKEWING OF CD4+ T CELLS IN VITRO: IMPACT ON IMMUNOEDITING IN MDS
Kerkhoff, N, Bontkes, H.J, Kruger, D.T, Ruben, J.M, Westers, T.M, van de Loosdrecht, A.A
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
van der Helm, L.H, Veeger, N.J.G.M, Kooy, M. van Marwijk, Beeker, A, de Weerdt, O, de Groot, M, Alhan, C, Hoogendoorn, M, Laterveer, L, van de Loosdrecht, A.A, Koedam, J, Vellenga, E, Huls, G
Published in Leukemia research (01.08.2013)
Published in Leukemia research (01.08.2013)
Get full text
Journal Article
180 IMMUNOPHENOTYPIC ANALYSIS OF ERYTHROID DYSPLASIA IN MYELODYSPLASTIC SYNDROMES. A REPORT ON BEHALF OF THE INTERNATIONAL AND EUROPEAN LEUKEMIANET IMDS-FLOW WORKING GROUP
Westers, T.M, Cremers, E.M.P, Oelschlaegel, U, Johansson, U, Bettelheim, P, Witte, B.I, Porta, M.G. Della, Kern, W, van de Loosdrecht, A.A
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2
Chamuleau, M.E.D, Ossenkoppele, G.J, van Rhenen, A, van Dreunen, L, Jirka, S.M.G, Zevenbergen, A, Schuurhuis, G.J, van de Loosdrecht, A.A
Published in Leukemia research (01.06.2011)
Published in Leukemia research (01.06.2011)
Get full text
Journal Article
P-095 A five parameter based flow cytometric scoring system refines the revised International Prognostic Scoring System for myelodysplastic syndromes
Alhan, C, Westers, T.M, Cremers, E.M.P, Cali, C, Ossenkoppele, G.J, Van de Loosdrecht, A.A
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
P-057 Myelodysplastic syndromes (MDS) with a deletion 5q display a specific immunophenotypic profile
Oelschlaegel, U, Westers, T.M, Mohr, B, Parmentier, S, Sockel, K, Bornhäuser, M, Van de Loosdrecht, A.A, Platzbecker, U
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
P-051 Flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
Westers, T.M, Kern, W, Ireland, R, Béné, M.C, Porta, M.G. Della, Ogata, K, Van de Loosdrecht, A.A
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
P-078 Flow cytometry has a high negative predictive value for excluding MDS in patients with cytopenia and indeterminate cytomorphology and cytogenetics
Cremers, E.M.P, Westers, T.M, Alhan, C, Wondergem, M.J, Cali, C, Schouten, C.W.M, Ossenkoppele, G.J, Van de Loosdrecht, A.A
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
62 MUTATIONS IN EPIGENETIC REGULATORS ARE SIGNIFICANTLY ASSOCIATED WITH ABERRANT EXPRESSION OF MYELOID DIFFERENTIATION ANTIGENS ON MYELOID PROGENITOR CELLS IN LOW/INTERMEDIATE RISK MDS
Coelho, P. Silva, Cremers, E.M.P, Westers, T.M, de Graaf, A.O, Alhan, C, Cali, C, Visser-Wisselaar, H.A, Chitu, D.A, Vellenga, E, Klein, S.K, Wijermans, P.W, de Greef, G.E, Legdeur, M.C, Muus, P, Ossenkoppele, G.J, Stevens-Kroef, M.J.P.L, van der Reijden, B, Jansen, J.H, van de Loosdrecht, A.A
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
O-027 European distribution of usage and impact on outcome for treatment with erythropoietic stimulating agents within the EUMDS lower-risk registry programme
Garelius, H, Johnston, W.T, Van de Loosdrecht, A.A, Park, S, De Swart, L, Stauder, R, Symeonidis, A, Sanz, G, Cermak, J, Georgescu, O, Skov-Holm, M, Germing, U, Fenaux, P, MacKenzie, M, Malcovati, L, Madry, K, Almeida, A.M. Antonio Medina, Bowen, D, De Witte, T, Smith, A, Hellström-Lindberg, E
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
P49 The treatment of patients with Myelodysplastic Syndromes in an era of application of new treatment modalities in an outpatient setting requires a multidisciplinary approach
Eeltink, C, Ossenkoppele, G.J, van de Loosdrecht, A.A
Published in European journal of oncology nursing : the official journal of European Oncology Nursing Society (2010)
Published in European journal of oncology nursing : the official journal of European Oncology Nursing Society (2010)
Get full text
Journal Article
286 The presence of aberrant myeloid progenitors predicts overall survival in intermediate-2 and high risk myelodysplastic syndromes upon treatment with azacitidine
Alhan, C, Westers, T.M, Eeltink, C, Cali, C, Huls, G, Ossenkoppele, G.J, van de Loosdrecht, A.A
Published in Leukemia research (2011)
Published in Leukemia research (2011)
Get full text
Journal Article
190 Efficacy of azacitidine and predictive factors for response in MDS and AML patients in the Dutch compassionate patient named programme
van der Helm, L, Alhan, C, Wijermans, P.W, van Marwijk Kooy, R, Schaafsma, R, Biemond, B.J, Beeker, A, Hoogendoorn, M, van Rees, B.P, de Weerdt, O, Wegman, J, Libourel, E.J, Luykx-de Bakker, S.A, Minnema, M.C, Brouwer, R.E, Croon-de Boer, F, Eefting, M, Jie, A, van de Loosdrecht, A.A, Koedam, J, Veeger, N, Vellenga, E, Huls, G.A
Published in Leukemia research (2011)
Published in Leukemia research (2011)
Get full text
Journal Article
137 Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
Westers, T.M, Ireland, R, Kern, W, Alhan, C, Balleisen, J.S, Béné, M.C, Bettelheim, P, Burbury, K, Cullen, M, Cutler, J.A, Porta, M.G. Della, Drager, A.M, Feuillard, J, Font, P, Germing, U, Haase, D, Johansson, U, Kordasti, S, Loken, M.R, Malcovati, L, te Marvelde, J.G, Matarraz, S, Milne, T, Moshaver, B, Mufti, G.J, Ogata, K, Orfao, A, Porwit, A, Psarra, K, Richards, S.J, Subirá, D, Tindell, V, Vallespi, T, Valent, P, van der Velden, V.H, de Witte, T.M, Wells, D.A, Zettl, F, van de Loosdrecht, A.A
Published in Leukemia research (2011)
Published in Leukemia research (2011)
Get full text
Journal Article
P093 Changes in the flowcytometric dysplasia score during treatment with erythropoietin/G-CSF reflect responses in low/int-I risk myelodysplastic syndromes
Westers, T.M, Chamuleau, M.E.D, Westra, A.H, Dräger, A.M, Ossenkoppele, G.J, van de Loosdrecht, A.A
Published in Leukemia research (2007)
Published in Leukemia research (2007)
Get full text
Journal Article
P037 Treatment with Epo/G-CSF of patients with low/int-I risk myelodysplastic syndrome diminishes relative CLIP (class II-associated invariant chain peptide) amount on hematopoietic precursor cells
Chamuleau, M.E.D, Zevenbergen, A, van Dreunen, L, Westers, T.M, Ossenkoppele, G.J, van de Loosdrecht, A.A
Published in Leukemia research (2007)
Published in Leukemia research (2007)
Get full text
Journal Article